Letter by Keidar and Gamliel-Lazarovich regarding article, "Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial"

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation (New York, N.Y.) N.Y.), 2012-05, Vol.125 (18), p.e653; author reply e654-e653; author reply e654
Hauptverfasser:	Keidar, Shlomo, Gamliel-Lazarovich, Aviva
Format:	Artikel
Sprache:	eng
Schlagworte:	Blood Pressure - drug effects Cytochrome P-450 CYP11B2 - antagonists & inhibitors Enzyme Inhibitors - administration & dosage Female Humans Hypertension - drug therapy Hypertension - enzymology Male
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	e653; author reply e654
container_issue	18
container_start_page	e653; author reply e654
container_title	Circulation (New York, N.Y.)
container_volume	125
creator	Keidar, Shlomo Gamliel-Lazarovich, Aviva
description
doi_str_mv	10.1161/CIRCULATIONAHA.111.080341
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1011851363</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1011851363</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-2d36d83408b20e1e8b55c0787bf776acd8ef707075653a50917eb9cf481537fb3</originalsourceid><addsrcrecordid>eNpVUdtq3DAQFaWl2aT9haLmqQ9xKlmW7e3bsqTJUtNASZ6NLuOsiiy5kryw-eP-RZXsJlAGMcxwLoMOQp8puaS0pl_Xm1_r-251t7n9ubpZ5R29JC1hFX2DFpSXVVFxtnyLFoSQZdGwsjxBpzH-zmPNGv4enZQlr2vG6wX620FKELDc4x9gtAhYOI2vxWgN2KITjyL4nVFbHOBBBG3cAxYhGWXhAp9fDQOoFLEfsMDO78BiYbWPWdA7wHHv0lZEwMZtjTTJBzzklwKINIJLT7wpmFGEPd7uJwgJXDTefctmcbYvwiFf5EfzCPoCaz9LC4W0xuVpskKB9MXzzUIls4NCeZeCtxY0np7Ny2xohD3_gN4Nwkb4eOxn6P771d36puhurzfrVVcoVrepKDWrdcsq0sqSAIVWcq5I0zZyaJpaKN3C0JBcvOZMcLKkDcilGqqWctYMkp2hLwfdKfg_M8TUjyYqsFY48HPsKaG05ZTVLEOXB6gKPsYAQ3_8jgzqn5Lu_08672h_SDpzPx1tZjmCfmW-RMv-AfcsqvE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1011851363</pqid></control><display><type>article</type><title>Letter by Keidar and Gamliel-Lazarovich regarding article, "Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial"</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Keidar, Shlomo ; Gamliel-Lazarovich, Aviva</creator><creatorcontrib>Keidar, Shlomo ; Gamliel-Lazarovich, Aviva</creatorcontrib><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/CIRCULATIONAHA.111.080341</identifier><identifier>PMID: 22566356</identifier><language>eng</language><publisher>United States</publisher><subject>Blood Pressure - drug effects ; Cytochrome P-450 CYP11B2 - antagonists & inhibitors ; Enzyme Inhibitors - administration & dosage ; Female ; Humans ; Hypertension - drug therapy ; Hypertension - enzymology ; Male</subject><ispartof>Circulation (New York, N.Y.), 2012-05, Vol.125 (18), p.e653; author reply e654-e653; author reply e654</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-2d36d83408b20e1e8b55c0787bf776acd8ef707075653a50917eb9cf481537fb3</citedby><cites>FETCH-LOGICAL-c368t-2d36d83408b20e1e8b55c0787bf776acd8ef707075653a50917eb9cf481537fb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3687,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22566356$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Keidar, Shlomo</creatorcontrib><creatorcontrib>Gamliel-Lazarovich, Aviva</creatorcontrib><title>Letter by Keidar and Gamliel-Lazarovich regarding article, "Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial"</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><subject>Blood Pressure - drug effects</subject><subject>Cytochrome P-450 CYP11B2 - antagonists & inhibitors</subject><subject>Enzyme Inhibitors - administration & dosage</subject><subject>Female</subject><subject>Humans</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - enzymology</subject><subject>Male</subject><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUdtq3DAQFaWl2aT9haLmqQ9xKlmW7e3bsqTJUtNASZ6NLuOsiiy5kryw-eP-RZXsJlAGMcxwLoMOQp8puaS0pl_Xm1_r-251t7n9ubpZ5R29JC1hFX2DFpSXVVFxtnyLFoSQZdGwsjxBpzH-zmPNGv4enZQlr2vG6wX620FKELDc4x9gtAhYOI2vxWgN2KITjyL4nVFbHOBBBG3cAxYhGWXhAp9fDQOoFLEfsMDO78BiYbWPWdA7wHHv0lZEwMZtjTTJBzzklwKINIJLT7wpmFGEPd7uJwgJXDTefctmcbYvwiFf5EfzCPoCaz9LC4W0xuVpskKB9MXzzUIls4NCeZeCtxY0np7Ny2xohD3_gN4Nwkb4eOxn6P771d36puhurzfrVVcoVrepKDWrdcsq0sqSAIVWcq5I0zZyaJpaKN3C0JBcvOZMcLKkDcilGqqWctYMkp2hLwfdKfg_M8TUjyYqsFY48HPsKaG05ZTVLEOXB6gKPsYAQ3_8jgzqn5Lu_08672h_SDpzPx1tZjmCfmW-RMv-AfcsqvE</recordid><startdate>20120508</startdate><enddate>20120508</enddate><creator>Keidar, Shlomo</creator><creator>Gamliel-Lazarovich, Aviva</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120508</creationdate><title>Letter by Keidar and Gamliel-Lazarovich regarding article, "Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial"</title><author>Keidar, Shlomo ; Gamliel-Lazarovich, Aviva</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-2d36d83408b20e1e8b55c0787bf776acd8ef707075653a50917eb9cf481537fb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Blood Pressure - drug effects</topic><topic>Cytochrome P-450 CYP11B2 - antagonists & inhibitors</topic><topic>Enzyme Inhibitors - administration & dosage</topic><topic>Female</topic><topic>Humans</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - enzymology</topic><topic>Male</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Keidar, Shlomo</creatorcontrib><creatorcontrib>Gamliel-Lazarovich, Aviva</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Keidar, Shlomo</au><au>Gamliel-Lazarovich, Aviva</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Letter by Keidar and Gamliel-Lazarovich regarding article, "Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial"</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>2012-05-08</date><risdate>2012</risdate><volume>125</volume><issue>18</issue><spage>e653; author reply e654</spage><epage>e653; author reply e654</epage><pages>e653; author reply e654-e653; author reply e654</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><cop>United States</cop><pmid>22566356</pmid><doi>10.1161/CIRCULATIONAHA.111.080341</doi><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0009-7322
ispartof	Circulation (New York, N.Y.), 2012-05, Vol.125 (18), p.e653; author reply e654-e653; author reply e654
issn	0009-7322 1524-4539
language	eng
recordid	cdi_proquest_miscellaneous_1011851363
source	MEDLINE; American Heart Association Journals; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals
subjects	Blood Pressure - drug effects Cytochrome P-450 CYP11B2 - antagonists & inhibitors Enzyme Inhibitors - administration & dosage Female Humans Hypertension - drug therapy Hypertension - enzymology Male
title	Letter by Keidar and Gamliel-Lazarovich regarding article, "Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial"
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T07%3A51%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Letter%20by%20Keidar%20and%20Gamliel-Lazarovich%20regarding%20article,%20%22Effects%20of%20a%20novel%20aldosterone%20synthase%20inhibitor%20for%20treatment%20of%20primary%20hypertension:%20results%20of%20a%20randomized,%20double-blind,%20placebo-%20and%20active-controlled%20phase%202%20trial%22&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=Keidar,%20Shlomo&rft.date=2012-05-08&rft.volume=125&rft.issue=18&rft.spage=e653;%20author%20reply%20e654&rft.epage=e653;%20author%20reply%20e654&rft.pages=e653;%20author%20reply%20e654-e653;%20author%20reply%20e654&rft.issn=0009-7322&rft.eissn=1524-4539&rft_id=info:doi/10.1161/CIRCULATIONAHA.111.080341&rft_dat=%3Cproquest_cross%3E1011851363%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1011851363&rft_id=info:pmid/22566356&rfr_iscdi=true